These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 8529333)

  • 1. Neuropeptide Y in human hand veins: pharmacologic characterization and interaction with cyclic guanosine monophosphate-dependent venodilators in vivo.
    Peduzzi P; Simper D; Linder L; Strobel WM; Haefeli WE
    Clin Pharmacol Ther; 1995 Dec; 58(6):675-83. PubMed ID: 8529333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased vascular alpha1-adrenergic sensitivity in patients with renal failure: receiving recombinant erythropoeitin.
    Abiose AK; Aronow WS; Moreno H; Nair CK; Blaschke TF; Hoffman BB
    Am J Ther; 2007; 14(5):427-34. PubMed ID: 17890929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indirect evidence for stimulation of nitric oxide release by tumour necrosis factor-alpha in human veins in vivo.
    Simper D; Strobel WM; Linder L; Haefeli WE
    Cardiovasc Res; 1995 Dec; 30(6):960-4. PubMed ID: 8746212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venous neuropeptide Y receptor responsiveness in patients with chronic heart failure.
    Feng Q; Lambert ML; Callow ID; Arnold JM
    Clin Pharmacol Ther; 2000 Mar; 67(3):292-8. PubMed ID: 10741633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicotine impairs endothelium-dependent dilatation in human veins in vivo.
    Chalon S; Moreno H; Benowitz NL; Hoffman BB; Blaschke TF
    Clin Pharmacol Ther; 2000 Apr; 67(4):391-7. PubMed ID: 10801248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subconstrictor doses of neuropeptide Y potentiate alpha 1-adrenergic venoconstriction in vivo.
    Linder L; Lautenschlager BM; Haefeli WE
    Hypertension; 1996 Sep; 28(3):483-7. PubMed ID: 8794837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Responsiveness of superficial hand veins to phenylephrine in essential hypertension. Alpha adrenergic blockade during prazosin therapy.
    Eichler HG; Ford GA; Blaschke TF; Swislocki A; Hoffman BB
    J Clin Invest; 1989 Jan; 83(1):108-12. PubMed ID: 2562959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo receptor characterization of neuropeptide Y-induced effects in consecutive vascular sections of cat skeletal muscle.
    Ekelund U; Erlinge D
    Br J Pharmacol; 1997 Feb; 120(3):387-92. PubMed ID: 9031740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substance P in human hand veins in vivo: tolerance, efficacy, potency, and mechanism of venodilator action.
    Strobel WM; Lüscher TF; Simper D; Linder L; Haefeli WE
    Clin Pharmacol Ther; 1996 Oct; 60(4):435-43. PubMed ID: 8873691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amiodarone causes endothelium-dependent vasodilation in human hand veins in vivo.
    Grossman M; Dobrev D; Kirch W
    Clin Pharmacol Ther; 1998 Sep; 64(3):302-11. PubMed ID: 9757154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnesium-induced vasodilation in the dorsal hand vein.
    Landau R; Scott JA; Smiley RM
    BJOG; 2004 May; 111(5):446-51. PubMed ID: 15104608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct effects of vasoactive substances on superficial human veins in vivo.
    Aellig WH
    Int Angiol; 1985; 4(2):235-42. PubMed ID: 3913713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The neuropeptide Y (NPY) Y1 receptor antagonist BIBP 3226: equal effects on vascular responses to exogenous and endogenous NPY in the pig in vivo.
    Malmström RE; Balmér KC; Lundberg JM
    Br J Pharmacol; 1997 Jun; 121(3):595-603. PubMed ID: 9179405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human beta2-adrenergic receptor gene haplotypes and venodilation in vivo.
    Bruck H; Leineweber K; Park J; Weber M; Heusch G; Philipp T; Brodde OE
    Clin Pharmacol Ther; 2005 Sep; 78(3):232-8. PubMed ID: 16153394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local venous response to N-desethylamiodarone in humans.
    Grossmann M; Dobrev D; Himmel HM; Kirch W
    Clin Pharmacol Ther; 2000 Jan; 67(1):22-31. PubMed ID: 10668850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelium-dependent modulation of venoconstriction to sarafotoxin S6c in human veins in vivo.
    Strachan FE; Haynes WG; Webb DJ
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S180-2. PubMed ID: 8587356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropeptide Y-induced potentiation of noradrenergic vasoconstriction in the human saphenous vein: involvement of endothelium generated thromboxane.
    Fabi F; Argiolas L; Ruvolo G; del Basso P
    Br J Pharmacol; 1998 May; 124(1):101-10. PubMed ID: 9630349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of angiotensin-converting enzyme in human hand veins.
    Chalon S; Bedarida GV; Moreno H; Tejura B; Urae A; Hoffman BB; Blaschke TF
    Clin Pharmacol Ther; 1999 Jan; 65(1):58-65. PubMed ID: 9951431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human response to alpha2-adrenergic agonist stimulation studied in an isolated vascular bed in vivo: Biphasic influence of dose, age, gender, and receptor genotype.
    King D; Etzel JP; Chopra S; Smith J; Cadman PE; Rao F; Funk SD; Rana BK; Schork NJ; Insel PA; O'Connor DT
    Clin Pharmacol Ther; 2005 May; 77(5):388-403. PubMed ID: 15900285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct angiotensin converting enzyme inhibitor-mediated venodilation.
    Zarnke KB; Feldman RD
    Clin Pharmacol Ther; 1996 May; 59(5):559-68. PubMed ID: 8646827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.